Smart Inhalers Market Size, Share, Growth Analysis, Trends And Forecast 2024-2033

Overview and Scope

Smart inhalers refer to medical devices that integrate connectivity with a mobile app, typically via Bluetooth. It is used to enhance the user experience and provide more personalized treatment decisions for individuals with chronic lung conditions such as asthma and chronic obstructive pulmonary disease (COPD).

 

Sizing and Forecast

The smart inhalers market size has grown strongly in recent years. It will grow from $1.48 billion in 2023 to $1.62 billion in 2024 at a compound annual growth rate (CAGR) of 9.9%.  The growth in the historic period can be attributed to increased medical adherence, increasing focus on patient-centric healthcare, growing demand for connected healthcare devices.

 

The smart inhalers market size is expected to see strong growth in the next few years. It will grow to $2.36 billion in 2028 at a compound annual growth rate (CAGR) of 9.8%. The growth in the forecast period can be attributed to rising prevalence of chronic respiratory diseases (CRDs), growing demand for home healthcare, increasing adoption of digital healthcare solutions. Major trends in the forecast period include technological advancements in smart inhalers, big data analytics, use of chip-on-sensors, advancements in sensor technology.

 

To access more details regarding this report, visit the link:

https://www.thebusinessresearchcompany.com/report/smart-inhalers-global-market-report

 

Segmentation & Regional Insights

The smart inhalers market covered in this report is segmented –

1) By Type: Dry Powdered Inhalers (DPIs), Metered Dose Inhalers (MDIs)

2) By Indication: Asthma, Chronic Obstructive Pulmonary Disease (COPD), Other Indications

3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

4) By End-User: Hospitals, Homecare Settings, Other End-Users

 

North America was the largest region in the smart inhalers market in 2023. The regions covered in the smart inhalers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

 

Intrigued to explore the contents? Secure your hands-on sample copy of the report:

https://www.thebusinessresearchcompany.com/sample_request?id=14196&type=smp

 

Major Driver Impacting Market Growth

The rising prevalence of chronic respiratory diseases (CRDs) is expected to boost the growth of the smart inhaler market going forward. Chronic respiratory diseases (CRDs) encompass a range of long-term conditions that affect the airways and other structures of the lungs. Smart inhalers, by tracking usage and offering reminders for missed doses, manage chronic respiratory diseases such as asthma and COPD, ensuring consistent medication use for symptom control and prevention of exacerbations. For instance, in June 2023, according to reports shared by the Australian Institute of Health and Welfare, an Australia-based national agency, there was a rise in respiratory disease-related deaths from 43,031 in 2020 to 46,551 in 2021 in Australia. Furthermore, in September 2022, according to the data published by The Lancet, a UK-based book and periodic data publishing organization, 11,255 new cases of RSV (respiratory syncytial virus) were recorded in 2021. Therefore, the rising prevalence of chronic respiratory diseases (CRDs) is driving the growth of the smart inhaler market.

 

Key Industry Players

Major companies operating in the smart inhalers market are Novartis AG, AstraZeneca Plc, GlaxoSmithKline Plc., 3M Health Care Limited, Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd., Berry Global Group Inc., Aptar Group Inc., Lupin Limited, Findair Sp.Z.o.o., OPKO Health Inc., Nemera France SAS, Vectura Group Limited, Propeller Health, Inspiro Medical Ltd., Biocorp Production, Cohero Health Inc., Pneuma Respiratory Inc., Amiko Digital Health Limited, Cognita Labs LLC, AireHealth Inc., Adherium Ltd., Zeolr Technologies Pvt Ltd., H&T Presspart Manufacturing Ltd.

 

The smart inhalers market report table of contents includes:

1. Executive Summary
2. Smart Inhalers Market Characteristics
3. Smart Inhalers Market Trends And Strategies
4. Smart Inhalers Market – Macro Economic Scenario
5. Global Smart Inhalers Market Size and Growth
6. Smart Inhalers Market Segmentation
7. Smart Inhalers Market Regional And Country Analysis

………………

34. Key Mergers And Acquisitions In The Smart Inhalers Market
35. Smart Inhalers Market Future Outlook and Potential Analysis
36. Appendix

 

List Of Tables:

Table 1: Global Historic Market Growth, 2018-2023, $ Billion

Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion

Table 3: Global Smart Inhalers Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 4: Global Smart Inhalers Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 5: Global Smart Inhalers Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

………….

Table 75: Novartis AG Financial Performance

Table 76: AstraZeneca Plc Financial Performance

Table 77: GlaxoSmithKline Plc. Financial Performance

Table 78: 3M Health Care Limited Financial Performance

Table 79: Boehringer Ingelheim International GmbH Financial Performance

 

Explore the trending research reports from TBRC:

https://goodprnews.com/high-precision-gnss-receiver-market-size/

https://topprnews.com/mass-transit-security-market-share/

 

Learn About Us:

The Business Research Company is a market intelligence firm that pioneers in market, company, and consumer research. TBRC’s specialist consultants are located globally and are experts in a wide range of industries that include healthcare, manufacturing, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.

 

Contact Us:

The Business Research Company

Europe: +44 207 1930 708

Asia: +91 88972 63534

Americas: +1 315 623 0293

Email: info@tbrc.info

 

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Twitter: https://twitter.com/tbrc_info

Facebook: https://www.facebook.com/TheBusinessResearchCompany

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Blog: https://blog.tbrc.info/

Healthcare Blog: https://healthcareresearchreports.com/

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model